PHILADELPHIA (CBS) – Several local cancer centers are taking part in a clinical trial of a drug to battle a deadly form of breast cancer.
The drug is aimed at a specific type of recurring breast cancer that has spread to other parts of the body.READ MORE: Brotherly Love: Wheels Of Change Bringing Help To Families In Their Own Neighborhoods
“This is a targeted silver bullet so to speak it’s going after that breast cancer cell that has this bump on it called the HER2+,” says Dr. David Henry, clinical professor of Medicine at Pennsylvania Hospital. “It attaches, has a little toxin right along for the ride — a Trojan horse so to speak. It goes right in and kills that breast cancer cell, so that’s the neat new development.”READ MORE: New Jersey Native, Who Lost Daughter In Parkland Shooting, Fighting To Protect School Children Across Nation
The trial needs 980 women. Half will be given the new drug, half the standard chemotherapy. You can find out more at EmiliaClinicalTrial.com.
Reported by Lynne Adkins, KYW Newsradio 1060MORE NEWS: Gunman Kills 19 Children, 2 Teachers In Texas School Rampage